CHG-2021-0104

Specification Change for Glucovantib. Formulation Change for Glucovantib — critical change. Impacts 4 markets and 3 variations.

Change Number
CHG-2021-0104
Type
Specification Change
Product
Glucovantib
Status
Blocked
Owner
Dmitri Volkov
Initiated
2023-11-12
Description

Formulation Change for Glucovantib — critical change

Impacted Markets (4)
JP — JapanDE — GermanyKR — South KoreaPL — Poland
Impacted Modules
3.2.P.34.2.12.3.P3.2.P
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved